Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer
Clinical trial NCT00079040 · COMPLETED
Trial details
- NCT number
- NCT00079040
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2009-01-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.